Compugen (CGEN) Shares Outstanding (2009 - 2026)
Compugen (CGEN) posted quarterly Shares Outstanding (Entity) of $94.6 million for Q1 2026, up 2.44% year-over-year from $92.3 million in Q1 2025, and up 1.21% on a QoQ basis from $93.4 million in Q4 2025.
Compugen (CGEN) Shares Outstanding (2009 - 2026) Analysis & Trends
Compugen has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $94.6 million in Q1 2026.
- Shares Outstanding (Entity) for Q1 2026 came in at $94.6 million, up 2.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $94.6 million (up 2.44% YoY), and the FY2025 annual result was $93.4 million, changed N/A from the prior year.
- Shares Outstanding (Entity) climbed to $94.6 million in Q1 2026, from $93.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $94.6 million in Q1 2026 and troughed at $86.5 million in Q1 2022.
- A 5-year average of $89.3 million and a median of $88.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2023, when Shares Outstanding (Entity) rose 0.2%; it then increased 3.8% in 2025.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $86.6 million in 2022, then advanced by 0.4% to $86.9 million in 2023, then increased by 3.01% to $89.5 million in 2024, then increased by 4.36% to $93.4 million in 2025, then increased by 1.21% to $94.6 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $94.6 million in Q1 2026, $93.4 million in Q4 2025, and $92.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 94.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.56 Mn |
| Dec 31, 2025 | 93.43 Mn |
| Sep 30, 2025 | 93.54 Mn |
| Jun 30, 2025 | 92.92 Mn |
| Mar 31, 2025 | 92.31 Mn |
| Dec 31, 2024 | 89.53 Mn |
| Sep 30, 2024 | 89.54 Mn |
| Jun 30, 2024 | 89.52 Mn |
| Mar 31, 2024 | 89.51 Mn |
| Dec 31, 2023 | 87.63 Mn |
| Sep 30, 2023 | 88.31 Mn |
| Jun 30, 2023 | 86.90 Mn |
| Mar 31, 2023 | 86.62 Mn |
| Dec 31, 2022 | 86.56 Mn |
| Sep 30, 2022 | 86.62 Mn |
| Jun 30, 2022 | 86.49 Mn |
| Mar 31, 2022 | 86.45 Mn |
| Dec 31, 2021 | 84.20 Mn |
| Sep 30, 2021 | 83.98 Mn |
| Jun 30, 2021 | 83.74 Mn |